Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy, increased ventricular stiffness and impaired diastolic filling. We investigated to what extent myocardial functional defects can be explained by alterations in the passive and active properties of human cardiac myofi...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2010
|
| _version_ | 1797066747819327488 |
|---|---|
| author | Hoskins, A Jacques, A Bardswell, S McKenna, W Tsang, V dos Remedios, C Ehler, E Adams, K Jalilzadeh, S Avkiran, M Watkins, H Redwood, C Marston, S Kentish, J |
| author_facet | Hoskins, A Jacques, A Bardswell, S McKenna, W Tsang, V dos Remedios, C Ehler, E Adams, K Jalilzadeh, S Avkiran, M Watkins, H Redwood, C Marston, S Kentish, J |
| author_sort | Hoskins, A |
| collection | OXFORD |
| description | Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy, increased ventricular stiffness and impaired diastolic filling. We investigated to what extent myocardial functional defects can be explained by alterations in the passive and active properties of human cardiac myofibrils. Skinned ventricular myocytes were prepared from patients with obstructive HCM (two patients with MYBPC3 mutations, one with a MYH7 mutation, and three with no mutation in either gene) and from four donors. Passive stiffness, viscous properties, and titin isoform expression were similar in HCM myocytes and donor myocytes. Maximal Ca(2+)-activated force was much lower in HCM myocytes (14 ± 1 kN/m(2)) than in donor myocytes (23 ± 3 kN/m(2); P<0.01), though cross-bridge kinetics (k(tr)) during maximal Ca(2)(+) activation were 10% faster in HCM myocytes. Myofibrillar Ca(2)(+) sensitivity in HCM myocytes (pCa(50)=6.40 ± 0.05) was higher than for donor myocytes (pCa(50)=6.09 ± 0.02; P<0.001) and was associated with reduced phosphorylation of troponin-I (ser-23/24) and MyBP-C (ser-282) in HCM myocytes. These characteristics were common to all six HCM patients and may therefore represent a secondary consequence of the known and unknown underlying genetic variants. Some HCM patients did however exhibit an altered relationship between force and cross-bridge kinetics at submaximal Ca(2+) concentrations, which may reflect the primary mutation. We conclude that the passive viscoelastic properties of the myocytes are unlikely to account for the increased stiffness of the HCM ventricle. However, the low maximum Ca(2+)-activated force and high Ca(2+) sensitivity of the myofilaments are likely to contribute substantially to any systolic and diastolic dysfunction, respectively, in hearts of HCM patients. |
| first_indexed | 2024-03-06T21:46:25Z |
| format | Journal article |
| id | oxford-uuid:49c16032-3852-4fc3-81ce-60054eb6f5f5 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:46:25Z |
| publishDate | 2010 |
| record_format | dspace |
| spelling | oxford-uuid:49c16032-3852-4fc3-81ce-60054eb6f5f52022-03-26T15:33:29ZNormal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:49c16032-3852-4fc3-81ce-60054eb6f5f5EnglishSymplectic Elements at Oxford2010Hoskins, AJacques, ABardswell, SMcKenna, WTsang, Vdos Remedios, CEhler, EAdams, KJalilzadeh, SAvkiran, MWatkins, HRedwood, CMarston, SKentish, JHypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy, increased ventricular stiffness and impaired diastolic filling. We investigated to what extent myocardial functional defects can be explained by alterations in the passive and active properties of human cardiac myofibrils. Skinned ventricular myocytes were prepared from patients with obstructive HCM (two patients with MYBPC3 mutations, one with a MYH7 mutation, and three with no mutation in either gene) and from four donors. Passive stiffness, viscous properties, and titin isoform expression were similar in HCM myocytes and donor myocytes. Maximal Ca(2+)-activated force was much lower in HCM myocytes (14 ± 1 kN/m(2)) than in donor myocytes (23 ± 3 kN/m(2); P<0.01), though cross-bridge kinetics (k(tr)) during maximal Ca(2)(+) activation were 10% faster in HCM myocytes. Myofibrillar Ca(2)(+) sensitivity in HCM myocytes (pCa(50)=6.40 ± 0.05) was higher than for donor myocytes (pCa(50)=6.09 ± 0.02; P<0.001) and was associated with reduced phosphorylation of troponin-I (ser-23/24) and MyBP-C (ser-282) in HCM myocytes. These characteristics were common to all six HCM patients and may therefore represent a secondary consequence of the known and unknown underlying genetic variants. Some HCM patients did however exhibit an altered relationship between force and cross-bridge kinetics at submaximal Ca(2+) concentrations, which may reflect the primary mutation. We conclude that the passive viscoelastic properties of the myocytes are unlikely to account for the increased stiffness of the HCM ventricle. However, the low maximum Ca(2+)-activated force and high Ca(2+) sensitivity of the myofilaments are likely to contribute substantially to any systolic and diastolic dysfunction, respectively, in hearts of HCM patients. |
| spellingShingle | Hoskins, A Jacques, A Bardswell, S McKenna, W Tsang, V dos Remedios, C Ehler, E Adams, K Jalilzadeh, S Avkiran, M Watkins, H Redwood, C Marston, S Kentish, J Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. |
| title | Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. |
| title_full | Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. |
| title_fullStr | Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. |
| title_full_unstemmed | Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. |
| title_short | Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. |
| title_sort | normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy |
| work_keys_str_mv | AT hoskinsa normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT jacquesa normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT bardswells normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT mckennaw normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT tsangv normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT dosremediosc normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT ehlere normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT adamsk normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT jalilzadehs normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT avkiranm normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT watkinsh normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT redwoodc normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT marstons normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy AT kentishj normalpassiveviscoelasticitybutabnormalmyofibrillarforcegenerationinhumanhypertrophiccardiomyopathy |